A very large-scale study population is needed for a longer period of time to enable significant new discoveries on genetic factors in diseases and disorders.
This requires investment on a scale that no single organization could support alone.
Together, Geisinger and Regeneron can provide the expertise, experience, and financial resources to fulfill the promise of this important research. The two organizations have agreed to an initial five-year partnership, which may be extended to ten years.
Under the partnership, Regeneron has agreed to uphold the same high standards of data security and personal privacy that Geisinger maintains for research participants.